A new study shows that delivery of gene therapy to correct the gene mutations that cause CLN2 disease, or Batten disease, directly into the cerebrospinal fluid (CSF) has potential therapeutic effects. The study, conducted ...
Sep 28, 2023
0
11
When our kidneys are acutely damaged, it can cause necrotic injury, which is the death of cells in the kidney. A new study from Aarhus University has now found that the cell damage spreads over several days after the immediate ...
Sep 26, 2023
0
12
Northwestern Medicine investigators have discovered how the protein PD-1 controls essential metabolic processes in tumor cells to promote cancer growth in T-cell non-Hodgkin lymphomas (T-NHLs), according to a study published ...
Sep 21, 2023
0
26
Many patients with recurrent acute pancreatitis (RAP) and acute pancreatitis (AP) have high lifetime cumulative drinking and heavy daily alcohol use, suggesting disease progression toward chronic pancreatitis, according to ...
Sep 20, 2023
0
0
The causes of Alzheimer's disease (AD) are unclear, and the interventions for AD are very limited. However, researchers led by Prof. He Zhuohao from the Shanghai Institute of Organic Chemistry of the Chinese Academy of Sciences, ...
Sep 14, 2023
0
86
A preclinical study led by Monash University has discovered a drug combination with the potential to treat one of the most fatal and globally widespread cancers, a type of primary liver cancer called hepatocellular carcinoma ...
Sep 14, 2023
0
34
New research from Vanderbilt University Medical Center finds that cerebrospinal fluid (CSF) net flow is markedly decreased in Huntington's disease (HD), with the decrease being greater in later stages of the disease.
Sep 13, 2023
0
41
Adding perioperative durvalumab to neoadjuvant chemotherapy did not adversely impact surgery in patients with resectable NSCLC and was associated with a tolerable surgical safety profile, according to research presented from ...
Sep 11, 2023
0
19
The sequencing of the human genome promised a revolution in medicine, but scientists soon realized that a genetic blueprint alone does not show the body in action. That required understanding the proteome—all the proteins, ...
Sep 11, 2023
0
183
The combination of benmelstobart, anlotinib, and chemotherapy demonstrated significant benefits compared to placebo and chemotherapy in terms of median progression-free survival and overall survival for patients with extensive-stage ...
Sep 11, 2023
0
1
